EAM INVESTORS, LLC – Neurocrine Biosciences, Inc. Transaction History
EAM INVESTORS, LLC portfolio value:
$1.41M
portfolio value
EAM INVESTORS, LLC quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +18.04% | 2.04K shares | 315K | $106.21 | 13.35K |
| Q2 2022 | share | Increase | 0.00% | 11.31K shares | 1.10M | $97.48 | 11.31K |
| Q2 2018 | share | Decrease | -100.00% | -41.52K shares | -3.44M | $98.24 | 0 |
| Q1 2018 | share | Increase | +8.49% | 3.24K shares | 474K | $82.93 | 41.52K |
| Q4 2017 | share | Decrease | -1.27% | -493 shares | 594K | $77.59 | 38.28K |
| Q3 2017 | share | Increase | 0.00% | 38.77K shares | 2.37M | $61.28 | 38.77K |
| Q3 2016 | share | Decrease | -100.00% | -55.89K shares | -2.54M | $50.64 | 0 |
| Q2 2016 | share | Decrease | -31.32% | -25.48K shares | -679K | $45.45 | 55.89K |
| Q1 2016 | share | Increase | +6.78% | 5.17K shares | -1.09M | $39.55 | 81.38K |